Sickle cell disease: role of reactive oxygen and nitrogen metabolites. [electronic resource]
- Clinical and experimental pharmacology & physiology Sep 2007
- 926-32 p. digital
Publication Type: Journal Article; Review
0305-1870
10.1111/j.1440-1681.2007.04639.x doi
Anemia, Sickle Cell--blood Animals Antioxidants--therapeutic use Antisickling Agents--pharmacology Endothelium, Vascular--drug effects Enzyme Inhibitors--therapeutic use Erythrocyte Aggregation Hemoglobin, Sickle--metabolism Hemolysis Humans Hydroxyurea--therapeutic use Iron Chelating Agents--therapeutic use Leukocyte Rolling NADPH Oxidases--antagonists & inhibitors Nitric Oxide--metabolism Nitric Oxide Synthase--metabolism Oxidative Stress--drug effects Platelet Adhesiveness Reactive Nitrogen Species--blood Reactive Oxygen Species--blood Vasodilation Xanthine Oxidase--metabolism